| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Catheterization | 30 | 2023 | 88 | 5.590 |
Why?
|
| Stroke | 19 | 2023 | 293 | 4.360 |
Why?
|
| Transcatheter Aortic Valve Replacement | 14 | 2023 | 27 | 4.060 |
Why?
|
| Atrial Appendage | 16 | 2023 | 45 | 3.970 |
Why?
|
| Atrial Fibrillation | 18 | 2023 | 183 | 3.920 |
Why?
|
| Cardiology | 19 | 2022 | 72 | 3.460 |
Why?
|
| Foramen Ovale, Patent | 10 | 2023 | 12 | 3.380 |
Why?
|
| Septal Occluder Device | 9 | 2023 | 17 | 2.100 |
Why?
|
| Heart Defects, Congenital | 5 | 2020 | 30 | 2.090 |
Why?
|
| Societies, Medical | 11 | 2020 | 190 | 2.070 |
Why?
|
| Aortic Valve Stenosis | 9 | 2023 | 23 | 1.940 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2022 | 6 | 1.630 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2021 | 42 | 1.500 |
Why?
|
| Cardiologists | 6 | 2023 | 14 | 1.420 |
Why?
|
| Treatment Outcome | 37 | 2023 | 3476 | 1.350 |
Why?
|
| Heart Valve Diseases | 7 | 2019 | 22 | 1.220 |
Why?
|
| Education, Medical, Graduate | 6 | 2020 | 79 | 1.220 |
Why?
|
| Humans | 88 | 2023 | 29361 | 1.150 |
Why?
|
| Consensus | 10 | 2020 | 104 | 1.130 |
Why?
|
| Embolism, Paradoxical | 4 | 2019 | 7 | 1.080 |
Why?
|
| Brain Ischemia | 2 | 2016 | 71 | 1.010 |
Why?
|
| Heart Valve Prosthesis Implantation | 4 | 2019 | 22 | 0.970 |
Why?
|
| Thoracic Surgery | 7 | 2019 | 28 | 0.910 |
Why?
|
| Angiography | 11 | 2023 | 38 | 0.870 |
Why?
|
| Heart Diseases | 3 | 2020 | 73 | 0.850 |
Why?
|
| Heart Failure | 2 | 2021 | 204 | 0.820 |
Why?
|
| Balloon Valvuloplasty | 3 | 2018 | 3 | 0.800 |
Why?
|
| Heart Valve Prosthesis | 5 | 2019 | 22 | 0.800 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2021 | 11 | 0.790 |
Why?
|
| Tricuspid Valve | 1 | 2020 | 3 | 0.790 |
Why?
|
| Heart-Assist Devices | 1 | 2021 | 22 | 0.780 |
Why?
|
| Education, Medical, Continuing | 2 | 2018 | 45 | 0.770 |
Why?
|
| Device Approval | 3 | 2018 | 15 | 0.750 |
Why?
|
| Aortic Valve | 5 | 2023 | 22 | 0.730 |
Why?
|
| Endovascular Procedures | 4 | 2020 | 33 | 0.720 |
Why?
|
| Health Resources | 1 | 2019 | 24 | 0.710 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 30 | 0.710 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2019 | 132 | 0.700 |
Why?
|
| Percutaneous Coronary Intervention | 4 | 2020 | 23 | 0.690 |
Why?
|
| Heart Block | 1 | 2019 | 19 | 0.690 |
Why?
|
| Education | 1 | 2018 | 39 | 0.650 |
Why?
|
| Stents | 8 | 2020 | 76 | 0.630 |
Why?
|
| United States | 15 | 2022 | 2332 | 0.620 |
Why?
|
| Coronary Angiography | 8 | 2020 | 91 | 0.620 |
Why?
|
| Practice Guidelines as Topic | 7 | 2020 | 333 | 0.600 |
Why?
|
| Hospital Mortality | 4 | 2020 | 141 | 0.580 |
Why?
|
| Risk Factors | 12 | 2023 | 2446 | 0.560 |
Why?
|
| Accreditation | 1 | 2016 | 16 | 0.560 |
Why?
|
| Therapeutic Occlusion | 1 | 2015 | 2 | 0.560 |
Why?
|
| Echocardiography | 9 | 2019 | 171 | 0.550 |
Why?
|
| Posture | 1 | 2015 | 78 | 0.540 |
Why?
|
| Certification | 1 | 2016 | 49 | 0.540 |
Why?
|
| Dyspnea | 1 | 2015 | 37 | 0.540 |
Why?
|
| Hypoxia | 1 | 2015 | 60 | 0.540 |
Why?
|
| Renal Dialysis | 1 | 2015 | 113 | 0.510 |
Why?
|
| Patient Care Team | 4 | 2019 | 140 | 0.460 |
Why?
|
| Female | 32 | 2022 | 16211 | 0.460 |
Why?
|
| Male | 29 | 2022 | 15637 | 0.450 |
Why?
|
| Myocardial Infarction | 4 | 2005 | 172 | 0.420 |
Why?
|
| Aged | 19 | 2022 | 9447 | 0.410 |
Why?
|
| Pulmonary Embolism | 2 | 2010 | 59 | 0.400 |
Why?
|
| Pulmonary Veins | 2 | 2020 | 23 | 0.400 |
Why?
|
| Prosthesis Design | 10 | 2020 | 502 | 0.400 |
Why?
|
| American Heart Association | 4 | 2019 | 29 | 0.390 |
Why?
|
| Thrombolytic Therapy | 4 | 2010 | 56 | 0.390 |
Why?
|
| Mitral Valve | 2 | 2019 | 13 | 0.370 |
Why?
|
| Clinical Competence | 5 | 2020 | 230 | 0.350 |
Why?
|
| Catheterization, Swan-Ganz | 2 | 2008 | 5 | 0.350 |
Why?
|
| Thrombectomy | 2 | 2010 | 27 | 0.350 |
Why?
|
| Pulmonary Artery | 3 | 2020 | 43 | 0.350 |
Why?
|
| Time Factors | 6 | 2020 | 1618 | 0.340 |
Why?
|
| Fibrinolytic Agents | 2 | 2010 | 56 | 0.340 |
Why?
|
| Migraine Disorders | 2 | 2007 | 14 | 0.340 |
Why?
|
| Hospital Costs | 2 | 2019 | 68 | 0.330 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2008 | 42 | 0.320 |
Why?
|
| Secondary Prevention | 4 | 2023 | 64 | 0.320 |
Why?
|
| Registries | 2 | 2020 | 189 | 0.320 |
Why?
|
| Aged, 80 and over | 9 | 2022 | 4851 | 0.320 |
Why?
|
| Thromboembolism | 2 | 2023 | 18 | 0.310 |
Why?
|
| Databases, Factual | 2 | 2019 | 330 | 0.310 |
Why?
|
| Thrombosis | 1 | 2008 | 59 | 0.310 |
Why?
|
| Inpatients | 2 | 2019 | 141 | 0.310 |
Why?
|
| Length of Stay | 2 | 2019 | 317 | 0.300 |
Why?
|
| Risk Assessment | 6 | 2020 | 678 | 0.290 |
Why?
|
| Cardiac Imaging Techniques | 4 | 2019 | 5 | 0.290 |
Why?
|
| Patient Selection | 6 | 2021 | 232 | 0.290 |
Why?
|
| Myocardial Ischemia | 2 | 2004 | 50 | 0.290 |
Why?
|
| Neurologists | 3 | 2023 | 8 | 0.290 |
Why?
|
| Tryptamines | 1 | 2005 | 3 | 0.270 |
Why?
|
| Oxazolidinones | 1 | 2005 | 6 | 0.270 |
Why?
|
| Heart Atria | 2 | 2020 | 74 | 0.270 |
Why?
|
| Angioplasty, Balloon, Coronary | 5 | 2004 | 47 | 0.260 |
Why?
|
| Pulmonary Valve Insufficiency | 2 | 2016 | 7 | 0.260 |
Why?
|
| Pulmonary Valve | 2 | 2016 | 8 | 0.260 |
Why?
|
| Coronary Aneurysm | 1 | 2004 | 2 | 0.250 |
Why?
|
| Hemorrhage | 2 | 2022 | 75 | 0.250 |
Why?
|
| Middle Aged | 19 | 2020 | 9823 | 0.240 |
Why?
|
| Follow-Up Studies | 5 | 2023 | 1829 | 0.240 |
Why?
|
| Retrospective Studies | 10 | 2023 | 3273 | 0.240 |
Why?
|
| Evidence-Based Medicine | 3 | 2020 | 206 | 0.230 |
Why?
|
| Anticoagulants | 2 | 2021 | 100 | 0.230 |
Why?
|
| Heart Transplantation | 2 | 2018 | 38 | 0.230 |
Why?
|
| Atrial Flutter | 1 | 2022 | 20 | 0.220 |
Why?
|
| Brachiocephalic Veins | 1 | 2002 | 1 | 0.220 |
Why?
|
| Abnormalities, Multiple | 1 | 2002 | 14 | 0.220 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2019 | 26 | 0.210 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2018 | 9 | 0.210 |
Why?
|
| Advisory Committees | 2 | 2020 | 34 | 0.210 |
Why?
|
| Guideline Adherence | 3 | 2017 | 67 | 0.200 |
Why?
|
| Vascular Surgical Procedures | 2 | 2016 | 24 | 0.200 |
Why?
|
| Recurrence | 6 | 2022 | 350 | 0.200 |
Why?
|
| Coronary Artery Bypass | 2 | 2000 | 32 | 0.200 |
Why?
|
| Quality of Health Care | 2 | 2019 | 137 | 0.190 |
Why?
|
| Metals | 2 | 2020 | 160 | 0.190 |
Why?
|
| Cryosurgery | 1 | 2020 | 20 | 0.190 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2013 | 16 | 0.190 |
Why?
|
| Polyesters | 1 | 2020 | 5 | 0.190 |
Why?
|
| Aorta, Abdominal | 1 | 2020 | 4 | 0.190 |
Why?
|
| Pleurisy | 1 | 2000 | 1 | 0.190 |
Why?
|
| Postpericardiotomy Syndrome | 1 | 2000 | 1 | 0.190 |
Why?
|
| Radiology, Interventional | 1 | 2020 | 6 | 0.190 |
Why?
|
| Manuals as Topic | 1 | 2020 | 2 | 0.190 |
Why?
|
| Survivors | 1 | 2020 | 57 | 0.180 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2019 | 9 | 0.180 |
Why?
|
| Catheter Ablation | 1 | 2020 | 78 | 0.180 |
Why?
|
| Angioplasty, Balloon | 3 | 2011 | 19 | 0.180 |
Why?
|
| Hepatic Veins | 1 | 2019 | 7 | 0.180 |
Why?
|
| Pulmonary Valve Stenosis | 2 | 2013 | 5 | 0.180 |
Why?
|
| Heart Valves | 1 | 2019 | 5 | 0.180 |
Why?
|
| Coronary Restenosis | 3 | 2004 | 11 | 0.180 |
Why?
|
| Catheterization, Peripheral | 1 | 2019 | 13 | 0.170 |
Why?
|
| Graft Occlusion, Vascular | 3 | 2004 | 24 | 0.170 |
Why?
|
| Physician's Role | 1 | 2018 | 17 | 0.170 |
Why?
|
| Cardiac Catheters | 1 | 2018 | 1 | 0.170 |
Why?
|
| Specialization | 1 | 2018 | 17 | 0.170 |
Why?
|
| Coronary Artery Disease | 3 | 2012 | 123 | 0.170 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2019 | 81 | 0.160 |
Why?
|
| Patient Discharge | 1 | 2019 | 149 | 0.160 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2017 | 770 | 0.160 |
Why?
|
| Azygos Vein | 1 | 2017 | 3 | 0.160 |
Why?
|
| Vena Cava, Inferior | 1 | 2017 | 10 | 0.160 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 222 | 0.150 |
Why?
|
| Incidental Findings | 1 | 2017 | 16 | 0.150 |
Why?
|
| Anesthesiology | 1 | 2017 | 30 | 0.150 |
Why?
|
| Chronic Disease | 1 | 2019 | 495 | 0.150 |
Why?
|
| Surgeons | 1 | 2018 | 76 | 0.150 |
Why?
|
| Health Care Surveys | 1 | 2017 | 67 | 0.150 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 61 | 0.150 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 90 | 0.150 |
Why?
|
| Myosins | 4 | 1984 | 7 | 0.150 |
Why?
|
| Bioprosthesis | 1 | 2016 | 8 | 0.150 |
Why?
|
| Animals | 9 | 2020 | 4577 | 0.150 |
Why?
|
| Physicians | 1 | 2018 | 115 | 0.140 |
Why?
|
| Internship and Residency | 1 | 2020 | 211 | 0.140 |
Why?
|
| Strontium Radioisotopes | 4 | 2003 | 12 | 0.140 |
Why?
|
| RNA, Messenger | 4 | 1984 | 323 | 0.140 |
Why?
|
| Adult | 11 | 2021 | 8604 | 0.140 |
Why?
|
| Education, Medical | 1 | 2016 | 49 | 0.130 |
Why?
|
| Oxygen | 1 | 2015 | 85 | 0.130 |
Why?
|
| Brachytherapy | 3 | 2004 | 47 | 0.130 |
Why?
|
| Clinical Decision-Making | 3 | 2019 | 36 | 0.120 |
Why?
|
| Beta Particles | 3 | 2003 | 10 | 0.120 |
Why?
|
| Stroke Volume | 2 | 2004 | 56 | 0.120 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 167 | 0.120 |
Why?
|
| Adolescent | 8 | 2016 | 2280 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2015 | 340 | 0.110 |
Why?
|
| Aortic Coarctation | 1 | 2011 | 2 | 0.100 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2008 | 44 | 0.100 |
Why?
|
| Equipment Design | 3 | 2018 | 185 | 0.100 |
Why?
|
| Ventricular Septum | 1 | 2010 | 2 | 0.100 |
Why?
|
| Fibronectins | 2 | 1982 | 29 | 0.100 |
Why?
|
| Heart Injuries | 1 | 2010 | 4 | 0.100 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2010 | 9 | 0.100 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2017 | 9 | 0.090 |
Why?
|
| Catechin | 1 | 2010 | 3 | 0.090 |
Why?
|
| Anti-Obesity Agents | 1 | 2010 | 5 | 0.090 |
Why?
|
| Plant Preparations | 1 | 2010 | 9 | 0.090 |
Why?
|
| Cloning, Molecular | 4 | 1984 | 32 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2010 | 53 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2020 | 227 | 0.090 |
Why?
|
| Young Adult | 5 | 2016 | 1935 | 0.090 |
Why?
|
| Punctures | 2 | 2019 | 10 | 0.090 |
Why?
|
| Hemodynamics | 3 | 2019 | 83 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 2 | 2019 | 39 | 0.080 |
Why?
|
| Prospective Studies | 6 | 2020 | 1812 | 0.080 |
Why?
|
| Computed Tomography Angiography | 2 | 2019 | 24 | 0.080 |
Why?
|
| Myocardium | 3 | 2001 | 140 | 0.080 |
Why?
|
| Learning Curve | 2 | 2019 | 18 | 0.080 |
Why?
|
| Workload | 2 | 2019 | 33 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2023 | 1113 | 0.080 |
Why?
|
| Europe | 2 | 2017 | 81 | 0.080 |
Why?
|
| Curriculum | 2 | 2020 | 155 | 0.080 |
Why?
|
| Torsades de Pointes | 1 | 2007 | 11 | 0.080 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 521 | 0.080 |
Why?
|
| Long QT Syndrome | 1 | 2007 | 17 | 0.080 |
Why?
|
| DNA | 3 | 1984 | 125 | 0.080 |
Why?
|
| Myocardial Revascularization | 2 | 2004 | 18 | 0.070 |
Why?
|
| Comorbidity | 1 | 2008 | 497 | 0.070 |
Why?
|
| Incidence | 3 | 2004 | 756 | 0.070 |
Why?
|
| Muscles | 2 | 1983 | 72 | 0.070 |
Why?
|
| Shock, Cardiogenic | 2 | 2010 | 10 | 0.070 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2005 | 9 | 0.070 |
Why?
|
| Child | 3 | 2016 | 1345 | 0.070 |
Why?
|
| Ultrasonography, Interventional | 2 | 2020 | 63 | 0.060 |
Why?
|
| Chicago | 3 | 2013 | 865 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 2 | 1982 | 260 | 0.060 |
Why?
|
| Coronary Stenosis | 1 | 2004 | 14 | 0.060 |
Why?
|
| Cardiac Volume | 1 | 2004 | 4 | 0.060 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2004 | 6 | 0.060 |
Why?
|
| Central Venous Pressure | 1 | 2004 | 5 | 0.060 |
Why?
|
| Diabetic Angiopathies | 1 | 2004 | 8 | 0.060 |
Why?
|
| Calcinosis | 1 | 2004 | 47 | 0.060 |
Why?
|
| Fluid Therapy | 1 | 2004 | 32 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 1984 | 99 | 0.060 |
Why?
|
| Sodium Chloride | 1 | 2004 | 37 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2004 | 86 | 0.060 |
Why?
|
| Pulmonary Circulation | 1 | 2002 | 4 | 0.060 |
Why?
|
| Heart Rate | 2 | 2018 | 142 | 0.050 |
Why?
|
| Visual Perception | 1 | 2002 | 50 | 0.050 |
Why?
|
| Health Status | 1 | 2023 | 227 | 0.050 |
Why?
|
| Brachiocephalic Trunk | 1 | 2001 | 1 | 0.050 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2001 | 2 | 0.050 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2001 | 3 | 0.050 |
Why?
|
| Syncope | 1 | 2001 | 8 | 0.050 |
Why?
|
| Medicare | 1 | 2022 | 121 | 0.050 |
Why?
|
| Neurology | 1 | 2022 | 101 | 0.050 |
Why?
|
| Electrophysiological Phenomena | 1 | 2020 | 12 | 0.050 |
Why?
|
| Cardiovascular Diseases | 3 | 2012 | 401 | 0.050 |
Why?
|
| Neointima | 1 | 2020 | 2 | 0.050 |
Why?
|
| Swine, Miniature | 1 | 2020 | 4 | 0.050 |
Why?
|
| Diffusion of Innovation | 1 | 2020 | 38 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2020 | 55 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2020 | 48 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 26 | 0.050 |
Why?
|
| Swine | 1 | 2020 | 80 | 0.050 |
Why?
|
| Chest Pain | 1 | 2000 | 24 | 0.050 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 28 | 0.050 |
Why?
|
| Writing | 1 | 2020 | 20 | 0.050 |
Why?
|
| Atrial Function, Left | 1 | 2019 | 2 | 0.040 |
Why?
|
| Materials Testing | 1 | 2020 | 137 | 0.040 |
Why?
|
| Cardiac Care Facilities | 1 | 2019 | 3 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2020 | 202 | 0.040 |
Why?
|
| Models, Organizational | 1 | 2019 | 27 | 0.040 |
Why?
|
| Subclavian Artery | 1 | 1999 | 4 | 0.040 |
Why?
|
| Credentialing | 1 | 2019 | 8 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 394 | 0.040 |
Why?
|
| Aortic Aneurysm | 1 | 1999 | 10 | 0.040 |
Why?
|
| Aneurysm | 1 | 1999 | 11 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2018 | 34 | 0.040 |
Why?
|
| Job Description | 1 | 2018 | 13 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 2019 | 49 | 0.040 |
Why?
|
| Neuroglia | 1 | 1979 | 39 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 1999 | 54 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2019 | 91 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2018 | 33 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 49 | 0.040 |
Why?
|
| Patient Safety | 1 | 2019 | 50 | 0.040 |
Why?
|
| Quality of Life | 1 | 2023 | 664 | 0.040 |
Why?
|
| Action Potentials | 1 | 2018 | 137 | 0.040 |
Why?
|
| Phlebography | 1 | 2017 | 9 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 553 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 70 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2019 | 158 | 0.040 |
Why?
|
| Canada | 1 | 2017 | 56 | 0.040 |
Why?
|
| Patient Participation | 1 | 2017 | 52 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2018 | 290 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2011 | 238 | 0.040 |
Why?
|
| Base Sequence | 4 | 1984 | 135 | 0.040 |
Why?
|
| Femoral Artery | 1 | 2016 | 14 | 0.040 |
Why?
|
| Radial Artery | 1 | 2016 | 10 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 1984 | 193 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 641 | 0.030 |
Why?
|
| Chick Embryo | 3 | 1983 | 20 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2013 | 19 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2004 | 324 | 0.030 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2003 | 29 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 150 | 0.030 |
Why?
|
| Risk | 1 | 2012 | 217 | 0.030 |
Why?
|
| Polytetrafluoroethylene | 1 | 2011 | 5 | 0.030 |
Why?
|
| Aortography | 1 | 2011 | 10 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 1184 | 0.030 |
Why?
|
| Periodicals as Topic | 1 | 2012 | 41 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2013 | 226 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2003 | 389 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1982 | 78 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2010 | 26 | 0.020 |
Why?
|
| Embolectomy | 1 | 2010 | 5 | 0.020 |
Why?
|
| Contraindications | 1 | 2010 | 41 | 0.020 |
Why?
|
| Hypotension | 1 | 2010 | 27 | 0.020 |
Why?
|
| Sympathomimetics | 1 | 2010 | 8 | 0.020 |
Why?
|
| Catheterization | 1 | 2010 | 51 | 0.020 |
Why?
|
| Survival Rate | 2 | 2002 | 349 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 3 | 1984 | 4 | 0.020 |
Why?
|
| Brain | 1 | 1979 | 1687 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2008 | 24 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 2008 | 20 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 175 | 0.020 |
Why?
|
| Mice | 3 | 1982 | 1620 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 400 | 0.020 |
Why?
|
| Prognosis | 1 | 2010 | 840 | 0.020 |
Why?
|
| Rabbits | 2 | 1984 | 283 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 2 | 1982 | 13 | 0.020 |
Why?
|
| Age Factors | 1 | 2008 | 845 | 0.020 |
Why?
|
| Hybridomas | 2 | 1982 | 19 | 0.020 |
Why?
|
| Plasmacytoma | 2 | 1982 | 18 | 0.020 |
Why?
|
| Lymphocytes | 2 | 1982 | 110 | 0.020 |
Why?
|
| Prevalence | 1 | 2007 | 491 | 0.020 |
Why?
|
| Gated Blood-Pool Imaging | 1 | 2004 | 1 | 0.020 |
Why?
|
| Cineangiography | 1 | 2004 | 3 | 0.020 |
Why?
|
| Myosin Subfragments | 1 | 1984 | 1 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2004 | 9 | 0.020 |
Why?
|
| Shock | 1 | 2004 | 9 | 0.020 |
Why?
|
| Resuscitation | 1 | 2004 | 18 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 145 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2004 | 76 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2004 | 44 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2004 | 75 | 0.010 |
Why?
|
| Endonucleases | 1 | 1983 | 1 | 0.010 |
Why?
|
| Endpoint Determination | 1 | 2003 | 28 | 0.010 |
Why?
|
| Logistic Models | 1 | 2004 | 407 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 113 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 159 | 0.010 |
Why?
|
| Hyperthyroidism | 1 | 1982 | 11 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1982 | 45 | 0.010 |
Why?
|
| Death | 1 | 2003 | 48 | 0.010 |
Why?
|
| Illinois | 1 | 2003 | 241 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 678 | 0.010 |
Why?
|
| Hypothyroidism | 1 | 1982 | 31 | 0.010 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2002 | 8 | 0.010 |
Why?
|
| Kinetics | 1 | 1982 | 225 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1982 | 264 | 0.010 |
Why?
|
| Erythropoietin | 1 | 1982 | 55 | 0.010 |
Why?
|
| Cell Line | 1 | 1982 | 299 | 0.010 |
Why?
|
| Random Allocation | 1 | 2002 | 146 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1983 | 284 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2001 | 46 | 0.010 |
Why?
|
| Biopsy | 1 | 2001 | 234 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 324 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 788 | 0.010 |
Why?
|
| Cell Separation | 1 | 1979 | 42 | 0.010 |
Why?
|
| Epitopes | 1 | 1979 | 81 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 1979 | 173 | 0.010 |
Why?
|
| Reoperation | 1 | 2002 | 933 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1979 | 676 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2001 | 1220 | 0.010 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1983 | 1 | 0.000 |
Why?
|
| Poly A | 1 | 1982 | 1 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1982 | 15 | 0.000 |
Why?
|
| Binding, Competitive | 1 | 1982 | 29 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1982 | 36 | 0.000 |
Why?
|
| Plasmids | 1 | 1982 | 44 | 0.000 |
Why?
|
| RNA | 1 | 1982 | 39 | 0.000 |
Why?
|
| Heart Ventricles | 1 | 1982 | 170 | 0.000 |
Why?
|
| Rats | 1 | 1982 | 858 | 0.000 |
Why?
|